Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Latent Epstein-Barr virus (EBV) infection and growth transformation of B lymphocytes is characterized by EBV nuclear and membrane protein expression (EBV nuclear antigen [EBNA] and latent membrane protein [LMP], respectively). LMP1 is known to be an oncogene in rodent fibroblasts and to induce B-lym...
Guardado en:
| Publicado en: | J Virol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1990
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC249392/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2157887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.64.5.2309-2318.1990 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
